FDA Drug Approvals and Changes: July Edition

Bhatt DL, et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013 Apr 4;368(14):1303-13. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa1300815
Anavip (Crotalidae immune FAB, equine) prescribing information. Rare Disease Therapeutics, Inc. Franklin, TN. May 2015. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM446175.pdf
Fycompa (perampanel) prescribing information. Eisai Inc., Woodcliff Lake, NJ. June 2015. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202834s005lbl.pdf
Zomig Nasal Spray (zolmitriptan) prescribing information. Impax Laboratories, Inc. Hayward, CA. June 2015. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021450s008lbl.pdf
Bussel JB, et al. PETIT and PETIT 2: Treatment with eltrombopag in 171 children with chronic immune thrombocytopenia (ITP). Presented at the 56^th ASH annual meeting and exposition. San Francisco, CA. December 6-9, 2014. Available at: https://ash.confex.com/ash/2014/webprogram/Paper68936.html
Busso M, Applebaum D. Hand augmentation with Radiesse (calcium hydroxylapatite). Dermatol Ther. 2007 Nov-Dec;20(6):385-7.

Author

Mary L Windle, PharmD
Editor-in-Chief, Medscape Drug Reference

Close<< Medscape

Mary L Windle, PharmD | July 23, 2015

Swipe to advance